+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 179688-29-0
179688-29-0,MFCD02678087
Catalog No.:AA002747

179688-29-0 | 6,7-Bis-(2-methoxyethoxy)-4(3h)-quinazolinone

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
98%
in stock  
$11.00   $8.00
- +
25g
98%
in stock  
$33.00   $23.00
- +
100g
98%
in stock  
$110.00   $77.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002747
Chemical Name:
6,7-Bis-(2-methoxyethoxy)-4(3h)-quinazolinone
CAS Number:
179688-29-0
Molecular Formula:
C14H18N2O5
Molecular Weight:
294.3031
MDL Number:
MFCD02678087
SMILES:
COCCOc1cc2c(cc1OCCOC)nc[nH]c2=O
Properties
Properties
 
BP:
467.8°C at 760 mmHg  
Form:
Solid  
MP:
185-189 °C  
Solubility:
DMSO: ≥10mg/mL  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
363  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
8  
XLogP3:
0.4  

Upstream Synthesis Route

[1]SyntheticCommunications,2014,vol.44,#3,p.346-351

[2]Tetrahedron,2010,vol.66,#4,p.962-968

[1]Patent:EP1477481,2004,A1,.Locationinpatent:Page20

[2]Patent:EP1650196,2006,A1,.Locationinpatent:Page/Pagecolumn7

[1]Patent:EP1477481,2004,A1,.Locationinpatent:Page19

[1]Patent:CN103709110,2016,B,.Locationinpatent:Paragraph0067;0068

[2]Patent:CN107382880,2017,A,.Locationinpatent:Paragraph0029-0041

[3]EuropeanJournalofMedicinalChemistry,2008,vol.43,#7,p.1478-1488

[1]OrganicLetters,2016,vol.18,#11,p.2580-2583

[2]Patent:CN107337648,2017,A,.Locationinpatent:Paragraph0011;0014

Downstream Synthesis Route

[1]Seimbille,Yann;Phelps,MichaelE.;Czernin,Johannes;Silverman,DanielH.S.[Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,#11,p.829-843]

[2]CurrentPatentAssignee:EDDINGPHARMCOLTD-CN103980207,2016,BLocationinpatent:Paragraph0041-0042

[3]CurrentPatentAssignee:YANGZHOUPOLYTECHNICINSTITUTE-CN107056724,2017,ALocationinpatent:Paragraph0046;0047;0048;0049;0050

[4]CurrentPatentAssignee:YANGZHOUPOLYTECHNICINSTITUTE-CN107235921,2017,ALocationinpatent:Paragraph0046;0047;0048;0049;0050

[5]CurrentPatentAssignee:YANGZHOUPOLYTECHNICINSTITUTE-CN107043356,2017,ALocationinpatent:Paragraph0046;0047;0048;0049;0050

[6]Chandregowda,Venkateshappa;VenkateswaraRao,Gudapati;ChandrasekaraReddy,Goukanapalli[Heterocycles,2007,vol.71,#1,p.39-48]

[7]CurrentPatentAssignee:SHENYANGUNIVERSITYOFTECHNOLOGY;LUCKYSHENYANGTECHINDUSTRIES;SHENYANGPHOTOSENSITIVECHEMICALRESINSTITUTE-CN108314657,2018,ALocationinpatent:Paragraph0027;0028;0030;0032-0034

[8]CurrentPatentAssignee:LAURUSLABSLIMITED-WO2013/156835,2013,A1Locationinpatent:Page/Pagecolumn13

[9]Locationinpatent:experimentalpartMarzaro,Giovanni;Guiotto,Adriano;Pastorini,Giovanni;Chilin,Adriana[Tetrahedron,2010,vol.66,#4,p.962-968]

[10]CurrentPatentAssignee:ZYDUSLIFESCIENCESLTD-US2014/121373,2014,A1Locationinpatent:Paragraph0109

[11]CurrentPatentAssignee:BEIJINGNORMALUNIVERSITY-CN103193722,2016,BLocationinpatent:Paragraph0118;0119;0120

[12]Li,Feng;Lu,Lei;Liu,Pengcheng[OrganicLetters,2016,vol.18,#11,p.2580-2583]

[13]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES-CN104945332,2017,BLocationinpatent:Paragraph0030-0031;0038-0039

[14]CurrentPatentAssignee:NANJINGUNIVERSITYOFSCIENCEANDTECHNOLOGY-CN107337648,2017,ALocationinpatent:Paragraph0011;0014;0015

[15]Chen,Fen-Er;Dong,Lin;Li,Hongyan;Liu,Jinxin;Luo,Liangliang;Xiao,You-Cai;Zhou,Yuan[RSCAdvances,2020,vol.10,#49,p.29257-29262]

[16]CurrentPatentAssignee:BEIJINGHAIBUPHARMACEUTICALTECH;CHINESEACADEMYOFSCIENCES-CN109096208,2018,ALocationinpatent:Paragraph0045-0047;0050

[17]Zou,Min;Jin,Bo;Liu,Yanrong;Chen,Huiping;Zhang,Zhuangli;Zhang,Changzheng;Zhao,Zhihong;Zheng,Liyun[Lettersindrugdesignanddiscovery,2018,vol.16,#2,p.102-110]

[18]CurrentPatentAssignee:HENANACADEMYOFSCIENCES-CN110092781,2019,ALocationinpatent:Paragraph0040

[19]Cheng,Weiyan;Wang,Suhua;Yang,Zhiheng;Tian,Xin;Hu,Yongzhou[DrugDesign,DevelopmentandTherapy,2019,vol.13,p.3079-3089]

[20]Lueth,Anja;Loewe,Werner[EuropeanJournalofMedicinalChemistry,2008,vol.43,#7,p.1478-1488]

[21]Knesl,Petr;Roeseling,Dirk;Jordis,Ulrich[Molecules,2006,vol.11,#4,p.286-297]

[22]CurrentPatentAssignee:FREIEUNIVERSITÄTBERLIN-WO2006/84882,2006,A2Locationinpatent:Page/Pagecolumn12

[23]CurrentPatentAssignee:TEVAPHARMACEUTICALINDUSTRIESLTD.-US2010/4449,2010,A1Locationinpatent:Page/Pagecolumn5-6

[24]Locationinpatent:schemeortableZheng,Youguang;Sun,Min;Liu,Yi;Li,Mingdong;Ji,Min[MedicinalChemistry,2011,vol.7,#4,p.295-300]

[25]Li,Shilei;Wang,Xiao;He,Yong;Zhao,Mingxia;Chen,Yurong;Xu,Jingli;Feng,Man;Chang,Jin;Ning,Hongyu;Qi,Chuanmin[EuropeanJournalofMedicinalChemistry,2013,vol.67,p.293-301]

[26]Maiden,TracyM.M.;Swanson,Stephen;Procopiou,PanayiotisA.;Harrity,JosephP.A.[Chemistry-AEuropeanJournal,2015,vol.21,#41,p.14342-14346]

[27]CurrentPatentAssignee:SHANGHAIFOSUNPHARMACEUTICAL(GROUP)CO.,LTD.-CN105801495,2016,ALocationinpatent:Paragraph0013;0014;0015;0016

[28]Zhang,Qingwei;Li,Yang;Zhang,Baoyin;Lu,Bingliu;Li,Jianqi[BioorganicandMedicinalChemistryLetters,2017,vol.27,#21,p.4885-4888]

[29]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;InstituteofChemistry(in:CAS)-CN107445907,2017,ALocationinpatent:Paragraph0062;0063;0064;0065

[30]CurrentPatentAssignee:SOUTHERNMEDICALUNIVERSITYCHINA;GUANGDONGSHENGSAIBIOTECHNOLOGYCOLTD;HOUYANSHENG-CN111333630,2020,ALocationinpatent:Paragraph0034-0036

[31]CurrentPatentAssignee:JIANGSUJOYANGLABORATORIESINC-CN111205233,2020,ALocationinpatent:Paragraph0009;0042-0047

[32]CurrentPatentAssignee:HENANUNIVERSITYOFCHINESEMEDICINE-CN112209888,2021,ALocationinpatent:Paragraph0024;0026

[33]Li,Zhonghua;Qin,Tingting;Li,Zhongrui;Zhao,Xuan;Zhang,Xinhui;Zhao,Taoqian;Yang,Nian;Miao,Jinxin;Ma,Jinlian;Zhang,Zhenqiang[EuropeanJournalofMedicinalChemistry,2021,vol.225]

[34]Zhang,Zixue;Zhang,Qingwei;Zhang,Hao;Jiao,Minru;Guo,Zheng;Peng,Xinyan;Fu,Lei;Li,Jianqi[BioorganicChemistry,2021,vol.117]

[35]Deng,Peng;Mao,Longfei;Peng,Lizeng;Sun,Ge;Yao,Kaitai;Yuan,Miaomiao;Zhao,Jie[FrontiersinPharmacology,2021,vol.12]

[1]Journaloflabelledcompoundsandradiopharmaceuticals,2005,vol.48,p.829-843

[1]Nakamura,Hiroyuki;Onagi,Shinya[TetrahedronLetters,2006,vol.47,#15,p.2539-2542]

[2]Zhang,Gengzhen;Zha,Linlin[ResearchonChemicalIntermediates,2013,vol.39,#6,p.2303-2309]

[3]CurrentPatentAssignee:SHENZHENSALUBRISPHARMACEUTICALSCO.,LTD.;CHINANATIONALPHARMACEUTICALGROUPCORPORATION-US2011/288086,2011,A1Locationinpatent:Page/Pagecolumn29

[4]CurrentPatentAssignee:SHENZHENSALUBRISPHARMACEUTICALSCO.,LTD.;CHINANATIONALPHARMACEUTICALGROUPCORPORATION-EP2592083,2013,A1Locationinpatent:Paragraph0261

[5]Chen,Zhe-Sheng;Dai,Qing-Qing;Li,Guo-Bo;Liu,Hong-Min;Liu,Hui;Wang,Bo;Wang,Shaomeng;Yu,Bin;Yuan,Shuo;Zhang,Jing-Ya;Zhang,Xiao-Nan;Zuo,Jia-Hui[JournalofMedicinalChemistry,2021,vol.64,#19,p.14895-14911]

[1]Molecules,2006,vol.11,p.286-297

[2]Patent:CN103193722,2016,B.Locationinpatent:Paragraph0115;0116;0117

[3]EuropeanJournalofMedicinalChemistry,2013,vol.67,p.293-301

[4]Journaloflabelledcompoundsandradiopharmaceuticals,2018,vol.61,p.42-53

236750-65-5   
CASUnavailable 
  179688-29-0 

[1]Chandregowda,Venkateshappa;VenkateswaraRao,Gudapati;ChandrasekaraReddy,Goukanapalli[Heterocycles,2007,vol.71,#1,p.39-48]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 179688-29-0
13794-72-4

13794-72-4

 162012-72-8

162012-72-8

 179688-52-9

179688-52-9

 179688-01-8

179688-01-8

 286371-64-0

286371-64-0

 28888-44-0

28888-44-0
Building Blocks
More >
Tags:179688-29-0 Molecular Formula|179688-29-0 MDL|179688-29-0 SMILES|179688-29-0 6,7-Bis-(2-methoxyethoxy)-4(3h)-quinazolinone |Organic_Building_Blocks